ICU Medical Inc ICUI

Morningstar Rating
$172.52 −3.24 (1.84%)
View Full Chart

Company Report

Price vs Fair Value

ICUI is trading within a range we consider fairly valued.
Price
$172.52
Fair Value
XyX
Uncertainty
LOCK|pX
1-Star Price
LOCK|V.p
5-Star Price
LOCK|@.&F
Economic Moat
LOCK|&b
Capital Allocation
LOCK|b^P$&&b

Bulls Say, Bears Say

Bulls

Management has done an impressive job deepening ICU's consumables portfolio through acquisitions and bolstering its leading position in this attractive end market.

Bears

ICU has struggled to consolidate its Smiths Medical acquisition, which has led to additional restructuring costs and has cast doubt on the firm’s ability to successfully integrate acquisitions.

News

Articles & Videos

Trading Information

Previous Close Price
$175.76
Day Range
$171.40–178.52
52-Week Range
$113.37–192.85
Bid/Ask
$172.41 / $172.65
Shares Outstanding
25.01M
Market Cap
$4.31B
Volume/Avg
223,435 / 252,249

Key Statistics

Price/Earnings (Normalized)
27.28
Price/Sales
1.99
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
13,000

Competitors

Valuation

Metric
ICUI
FRE
BAX
Price/Earnings (Normalized)
27.2817.6423.51
Price/Book Value
1.971.422.02
Price/Sales
1.991.231.13
Price/Cash Flow
11.9211.6511.27
Price/Earnings
ICUI
FRE
BAX

Financial Strength

Metric
ICUI
FRE
BAX
Quick Ratio
1.051.040.99
Current Ratio
2.371.521.79
Interest Coverage
1.388.390.21
Quick Ratio
ICUI
FRE
BAX

Profitability

Metric
ICUI
FRE
BAX
Return on Assets (Normalized)
3.76%5.13%4.82%
Return on Equity (Normalized)
7.05%11.03%15.04%
Return on Invested Capital (Normalized)
5.87%7.38%7.23%
Return on Assets
ICUI
FRE
BAX

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|F%J!Y&K?LOCK|KZ$138B
Becton Dickinson & Co
BDX
LOCK|J>SLOCK|!vrJ$58B
Alcon Inc
ALC
LOCK|^b!^D>gLOCK|C<ZT$35B
ResMed Inc
RMD
LOCK|mY!>Q#YLOCK|#!!H$33B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|^$sW%&LOCK|?v$Jx$33B
West Pharmaceutical Services Inc
WST
LOCK|^kh#JF%KLOCK|Hn>$27B
Solventum Corp
SOLV
LOCK|p?GM@&BLOCK|&#$14B
Baxter International Inc
BAX
LOCK|R?xLOCK|xW$MH$13B
The Cooper Companies Inc
COO
LOCK|X<%#&%%LOCK|r^@Bh$11B
Align Technology Inc
ALGN
LOCK|r>#<Y$TLOCK|cy!^$11B

Sponsor Center